Prenetics Expands BTC Holdings, Adds 100 BTC to Corporate Treasury
David Beckham backs , a well-known health science company, as they have made significant changes to their digital asset strategy by adding 100 BTC (BTC) to their corporate treasury.
This new purchase was announced on October 31, just days later than a very successful $44 million equity offering that was oversubscribed. Prenetics has strengthened its position in the rapidly evolving digital asset industry thanks to the new investment.
With the current purchase, Prenetics now owns 378 , which are worth about $41 million in total. Company records indicate that the current purchase cost is approximately $109,594 per BTC, demonstrating the company’s commitment to expanding its digital assets on the balance sheet.
Plan Supported by a Strong Capital Position
In June 2025, Prenetics made its first move into the BTC treasury market by purchaseing $20 million worth of . The company’s liquidity has improved significantly since it recently raised funds. It now has $127 million in cash and BTC, comprising approximately $86 million in cash reserves and $41 million in BTC.
The company remains debt-free, which puts it in a strong position for future expansion and affords it greater financial flexibility. Danny Yeung, the CEO, stated that the most recent transaction aligns with Prenetics’ long-term strategic objectives. Yeung noted that the acquisition is a direct result of the strategies shared with investors.
It will utilize the company’s stronger financial position to maximize value from both its operations and treasury. He pointed out that this strong liquidity ensures the company can achieve its goals of expansion and market leadership in all its business areas.
A Commitment to Strategic BTC Accumulation That Will Last
The company’s BTC-focused treasury strategy encompasses not only large, infrequent transactions but also smaller, regular transactions. Management has promised to purchase an additional 1 BTC every day, using the daily purchases to build up their holdings.
Additionally, Prenetics plans to make largeger, opportunistic acquisitions when the market is excellent, which in the past has meant purchaseing when the market is down.
IM8 Brand and Revenue Growth Are Still Top Priorities
Prenetics’ primary business growth remains the most significant aspect, even as they place greater emphasis on digital assets. The IM8 supplement brand has just reached a significant milestone: it now generates $100 million in yahead recurring revenue.
For the next fiscal year, the company anticipates generating between $180 million and $200 million in revenue. Leadership states that with the cash and BTC it has on hand, Prenetics is well-positioned to maintain IM8’s market leadership while also expanding its digital asset base for the long-term benefit of its shareholders.
Prenetics’ ambitious steps to build its demonstrate its commitment to both expanding its core business and acquiring digital assets. The company has a strong financial position and a clear dual focus, positioning it well to achieve its strategic goals for both shareholders and the broader market.
